These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14123837)

  • 1. THE SEPARATE HYPOLIPOPROTEINEMIC EFFECTS OF DEXTROTHYROXINE AND ETHYL CHLOROPHENOXYISOBUTYRATE.
    STRISOWER EH; STRISOWER B
    J Clin Endocrinol Metab; 1964 Feb; 24():139-44. PubMed ID: 14123837
    [No Abstract]   [Full Text] [Related]  

  • 2. REDUCTION OF SERUM TRIGLYCERIDES IN PATIENTS TREATED WITH SODIUM D-THYROXINE.
    FELDMAN EB; CARTER AC
    Metabolism; 1963 Dec; 12():1132-40. PubMed ID: 14100284
    [No Abstract]   [Full Text] [Related]  

  • 3. [ATROMID IN HYPERCHOLESTEROLEMIA AND HYPERLIPEMIA. LITERATURE REVIEW AND RESULTS OF CLINICAL TESTS].
    ENGSTROEM J
    Sven Lakartidn; 1964 Apr; 61():1446-57. PubMed ID: 14145138
    [No Abstract]   [Full Text] [Related]  

  • 4. THE EFFECT OF ETHYL CHLOROPHENOXYISOBUTYRATE ON THE BINDING BETWEEN TRIIODOTHYRONINE AND PROTEIN.
    MOGENSEN EF
    J Atheroscler Res; 1963; 3():415-7. PubMed ID: 14100882
    [No Abstract]   [Full Text] [Related]  

  • 5. EFFECT OF ETHYL CHLOROPHENOXYISOBUTYRATE WITH OR WITHOUT ANDROSTERONE ON PLATELET STICKINESS.
    SYMONS C; DETOSZEGHI A; COOK IJ
    Lancet; 1964 Aug; 2(7353):233-4. PubMed ID: 14163151
    [No Abstract]   [Full Text] [Related]  

  • 6. THE TREATMENT OF XANTHOMATOSIS WITH "ATROMID".
    MISHKEL MA
    Med J Aust; 1964 Nov; 2():828-33. PubMed ID: 14226559
    [No Abstract]   [Full Text] [Related]  

  • 7. REDUCTION OF SERUM CHOLESTEROL AND LIPIDS BY ETHYL CHLOROPHENOXYISOBUTYRATE.
    HELLMAN L; ZUMOFF B; KESSLER G; KARA E; RUBIN IL; ROSENFELD RS
    J Atheroscler Res; 1963; 3():454-66. PubMed ID: 14100886
    [No Abstract]   [Full Text] [Related]  

  • 8. "ATROMID" IN ATHEROSCLEROSIS.
    BARNETT AJ; CARSON V; DE MEIRING PV
    Med J Aust; 1964 Jul; 2():19-24. PubMed ID: 14175311
    [No Abstract]   [Full Text] [Related]  

  • 9. FURTHER OBSERVATIONS ON THE EFFECTS OF ATROMID AND OF ETHYL CHLOROPHENOXYISOBUTYRATE ON SERUM LIPID LEVELS.
    OLIVER MF
    J Atheroscler Res; 1963; 3():427-44. PubMed ID: 14100884
    [No Abstract]   [Full Text] [Related]  

  • 10. THE EFFECTS OF ATROMID ON SERUM LIPIDS, PROTEINS AND SOME LIVER FUNCTION TESTS IN HYPERCHOLESTEROLAEMIC PATIENTS.
    KONTTINEN A; PALOHEIMO J
    J Atheroscler Res; 1963; 3():525-32. PubMed ID: 14100893
    [No Abstract]   [Full Text] [Related]  

  • 11. HYPOLIPEMIA AND HEPATOMEGALY FROM ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB) IN THE RAT.
    BEST MM; DUNCAN CH
    J Lab Clin Med; 1964 Oct; 64():634-42. PubMed ID: 14233152
    [No Abstract]   [Full Text] [Related]  

  • 12. [CLINICAL STUDIES ON ATROMID. I. EFFECT OF ATROMID ON BLOOD SERUM LIPIDS AND LIVER FUNCTION TESTS].
    SZNAJDERMAN M; CISWICKA SZNAJDERMAN M; IGNATOWSKA H; GAJEWSKI J; SKORYKOW A
    Pol Arch Med Wewn; 1964; 34():1641-6. PubMed ID: 14323271
    [No Abstract]   [Full Text] [Related]  

  • 13. THE EFFECT OF ATROMID AND ATROMID-S ON PLASMA FIBRINOGEN AND PLASMINOGEN LEVELS.
    OGSTON CM; OGSTON D; MCANDREW GM
    Curr Ther Res Clin Exp; 1965 Aug; 7():437-42. PubMed ID: 14331671
    [No Abstract]   [Full Text] [Related]  

  • 14. EFFECT OF CLOFIBRATE AND ANDROSTERONE ON HYPERCHOLESTEROLAEMIC XANTHOMATOSIS.
    MASON B; PERRY CB
    Br Med J; 1965 Jan; 1(5427):102-3. PubMed ID: 14218460
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements.
    OLIVER MF; ROBERTS SD; HAYES D; PANTRIDGE JF; SUZMAN MM; BERSOHN I
    Lancet; 1963 Jan; 1(7273):143-4. PubMed ID: 13940003
    [No Abstract]   [Full Text] [Related]  

  • 16. MULTICENTRE TRIAL IN THE UNITED KINGDOM AND IRELAND OF A MIXTURE OF ETHYL CHLOROPHENOXYISOBUTYRATE AND ANDROSTERONE (ATROMID). A PRELIMINARY REPORT.
    GREEN KG; INMAN WH; THORP JM
    J Atheroscler Res; 1963; 3():593-616. PubMed ID: 14104298
    [No Abstract]   [Full Text] [Related]  

  • 17. THE EFFECT OF SF 20-10-5 CONCENTRATION CHANGES INDUCED BY ETHYL CHLOROPHENOXYISOBUTYRATE ON HIGH-DENSITY LIPOPROTEIN LIPID COMPOSITION.
    STRISOWER EH; NICHOLS AV; LINDGREN FT; SMITH L
    J Lab Clin Med; 1965 May; 65():748-55. PubMed ID: 14281371
    [No Abstract]   [Full Text] [Related]  

  • 18. [THE ACTION OF CLOFIBRATE-ANDROSTERONE ON THE PLASMA CHOLESTEROL AND LIPIDS].
    VASTESAEGER M; GILLOT P; DELCOURT R
    Brux Med; 1964 Aug; 44():357-75. PubMed ID: 14196801
    [No Abstract]   [Full Text] [Related]  

  • 19. THE EFFECTS OF CHLOROPHENOXYISOBUTYRATE WITH AND WITHOUT ANDROSTERONE ON THE SERUM LIPIDS, FAT TOLERANCE, AND URIC ACID.
    BERKOWITZ D
    Metabolism; 1965 Sep; 14():966-75. PubMed ID: 14327273
    [No Abstract]   [Full Text] [Related]  

  • 20. EFFECTS OF ETHYL CHLOROPHENOXYISOBUTYRATE, ALONE OR WITH ANDROSTERONE (ATROMID) ON SERUM LIPIDS, LIPOPROTEINS AND RELATED METABOLIC PARAMETERS IN NORMAL AND HYPERLIPIDEMIC SUBJECTS.
    HOWARD RP; ALAUPOVIC P; BRUSCO OJ; FURMAN RH
    J Atheroscler Res; 1963; 3():482-99. PubMed ID: 14100889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.